Cerebral vasospasm: resolution by iloprost, nocloprost and UK 38 485.
Türker
R K
RK
Department of Pharmacology, Faculty of Medicine, University of Ankara, Turkey.
Egemen
N
N
Deda
H
H
D000818:Animals; D001488:Basilar Artery / Q000187:drug effects / Q000503:physiopathology; D011464:Epoprostenol / Q000627:therapeutic use; D005260:Female; D016285:Iloprost; D007093:Imidazoles / Q000627:therapeutic use; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use; D011817:Rabbits; D014664:Vasodilation / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D007093:Imidazoles; D011461:Prostaglandins F, Synthetic; D014665:Vasodilator Agents; C039242:dazmegrel; C048895:nocloprost; D011464:Epoprostenol; D016285:Iloprost